Health Condition 1: I709- Other and unspecified atherosclerosis
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Torrent Pharmaceutical Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Male or female patients more than 18 years of age Stable CAD cases with effort or exertional Angina Stable CAD with effort Angina who have undergone CCTA or Angiography to delineate coronary anatomy for non obstructive CAD
Exclusion criteria
Exclusion criteria: Trop T more than 0 point 07 nano gram per ml and ECG changes with ST deviation more than 0 point 05 mV that require PCI Unstable or uncontrolled cases of CAD with Hypertension or signs of acute MI with blood pressure less than 100mmhg Cardiac shock Aortic dissection History of myocardial infarction or percutaneous coronary intervention or coronary artery bypass grafting less than 1 month Contraindicated or intolerable to nicorandil Patients on background use of Long acting nitrates Pregnant or lactation period Patients with an estimated survival time of less than 1 year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Canadian Cardiovascular Society CCS Angina score Timepoint: 4 week and 12 week | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Angina frequency at 12 W Change in impact on QoL at 12W Rescue medication use with sublingual Nitroglycerin at 12W Safety assessments in terms of AEs at 12WTimepoint: Follow up at 12 weeks Follow Up at 12 weeks Follow up at 12 weeks Follow Up at 12 weeks | — |
Countries
India
Contacts
Public ContactDr Krishna prasad K
Sawhney Heart Centre Delhi
Outcome results
None listed